I was very skeptical of getting an EUA on M2M results before the PR yesterday but the NEWS2 endpoint is the real deal and now I won't be surprised if it happens.
I won't be surprised at a phase 3 also, but those p values for NEWS2 should be very compelling in the eyes of the FDA.